Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Ulrich Laufs(University Hospital Leipzig), Erik S.G. Stroes(Amsterdam University Medical Centers), Maciej Banach(John Paul II Catholic University of Lublin), LeAnne T. Bloedon(Esperion Therapeutics (United States)), Daniel Gaudet(Brigham and Women's Hospital), G.B. John Mancini(Cedars-Sinai Medical Center), Stephanie Kelly(Esperion Therapeutics (United States)), Lulu Ren Sterling(Esperion Therapeutics (United States))
Cited by 431
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
|Nature Genetics|2000|1.8k